# Adaptimmune Therapeutics PLC: Form SC 13D/A, filed Mar 30, 2023

- Company: [Adaptimmune Therapeutics PLC](/companies/adapy.md) (CIK 1621227)
- Form: SC 13D/A
- Filed: 2023-03-30
- Accepted by EDGAR: Mar 30, 2023, 17:13 ET
- Period: not reported
- Accession: 0001072613-23-000276
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1621227/000107261323000276/nea14-adaptimmune_18706.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1621227/000107261323000276/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1621227/000107261323000276/nea14-adaptimmune_18706.htm

Filed Mar 30, 2023.
Source: SEC EDGAR, the filing index for accession 0001072613-23-000276. Last ingested by Listed: Oct 24, 2026, 15:14 ET. No prices; not investment advice.
